- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Prostate Carcinoma in New Zealand
Total 5157 results
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
DendreonCompletedProstate Cancer | Prostatic Neoplasm | Prostatic AdenocarcinomaUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Dana-Farber Cancer InstituteCompletedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Royal North Shore HospitalTerminatedMetastatic Castrate- Resistant Prostate CancerAustralia
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Duke UniversityCompleted
-
Ardeshir RastinehadPhilips HealthcareRecruitingProstate Cancer | Prostate Disease | Elevated Prostate Specific Antigen | Family History of Prostate Cancer | Positive Digital Rectal ExamUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | Stage I Prostate AdenocarcinomaUnited States, Canada, Switzerland
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
NYU Langone HealthCompleted
-
Resurge Therapeutics Inc.RecruitingLower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)New Zealand, Australia
-
National Human Genome Research Institute (NHGRI)Completed
-
Hoffmann-La RocheCompleted
-
The Rogosin InstituteCompleted
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingProstate CarcinomaUnited States
-
Progenics Pharmaceuticals, Inc.CompletedStudy of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer (CONDOR)Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Recurrent | Prostate Cancer MetastaticUnited States, Canada
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
BayerCompleted
-
University of Medicine and Dentistry of New JerseyUnited States Department of DefenseWithdrawnProstate CancerUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Tracon Pharmaceuticals Inc.Janssen Pharmaceutica N.V., BelgiumCompletedMetastatic Castrate-resistant Prostate Cancer | Adenocarcinoma, ProstateUnited States
-
Ferring PharmaceuticalsFerring Arzneimittel GmbHCompletedAndrogen Ablative Therapy of Advanced Hormone-dependent Prostate CarcinomaGermany
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
Light Sciences OncologyCompletedLower Urinary Tract Symptoms | Benign Prostatic HyperplasiaNew Zealand, Australia
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States
-
Janux TherapeuticsRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic CancerUnited States, Australia
-
Memorial Sloan Kettering Cancer CenterCapcureCompletedCancer | ProstateUnited States
-
Memorial Sloan Kettering Cancer CenterNo longer availableRecurrent Prostate Cancer | Prostate CancerUnited States
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Novartis PharmaceuticalsTerminatedHormone Refractory Prostate Cancer DiseaseUnited States
-
James J. Peters Veterans Affairs Medical CenterNot yet recruitingMetastatic Cancer | Neoplasm, ProstateUnited States
-
Genta IncorporatedUnknownProstate CancerUnited States
-
University of RochesterWithdrawnProstate DiseaseUnited States
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
University of RochesterWithdrawnProstate DiseaseUnited States
-
Weill Medical College of Cornell UniversityCompletedMetastatic Prostate CancerUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminated
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Lava TherapeuticsRecruitingMetastatic Castration Resistant Prostate CancerUnited States
-
AstraZenecaNot yet recruitingHepatocellular Carcinoma | Prostate CancerUnited States
-
NRG OncologyNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast CarcinomaUnited States, Canada, Switzerland